Dose-finding study of HP-3000 in patients with idiopathic restless legs syndrome.

Trial Profile

Dose-finding study of HP-3000 in patients with idiopathic restless legs syndrome.

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Jan 2017

At a glance

  • Drugs Ropinirole (Primary)
  • Indications Restless legs syndrome
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Hisamitsu Pharmaceutical
  • Most Recent Events

    • 02 Feb 2015 New trial record
    • 23 Oct 2014 Status changed from recruiting to completed, as reported in a Hisamitsu Pharmaceutical media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top